What We're Reading: Page 124
Industry reads hand-picked by our editors
May 11, 2022
-
The Wall Street Journal
This Biotech Flew High, Then Fell Hard When Its Cancer Drug Failed
-
The New York Times
Emergent Hid Evidence of Covid Vaccine Problems at Plant, Report Says
-
Reuters
J&J appoints consumer health head Thibaut Mongon to CEO of spun-off business
-
C&EN
A toxic twist on AI for drug design
May 10, 2022
-
Bloomberg
'Please Pay Attention': Scientist Flagged Heart-Pill Toxins Early On
-
Associated Press
Rare cases of COVID returning pose questions for Pfizer pill
-
The Wall Street Journal
Moderna Seeks to Dismiss Covid-19 Vaccine Patent Lawsuit
May 09, 2022
May 06, 2022
May 05, 2022
-
Bloomberg
Cancer Drug Developers Trade Below Cash With No Respite In Sight
-
The Washington Post
Duke's Klotman is under consideration as the next NIH head
-
MarketWatch
Drug companies are making an accounting change after the SEC cracked down on Biogen
-
MIT Technology Review
The xenotransplant patient who died received a heart infected with a pig virus
Previous
